Declared technologies base

TRANSFER OF INNOVATIONAL TECHNOLOGIES

PALLADIUM BISPHOSPHONATE - A NEW, NON-TOXIC ANTI-TUMOR FUNDS


Purpose of the development: Compounds for the treatment of bone cancer and metastasis in the bones, which occur in oncology of the mammary, prostate, thyroid, lung.

Recommended application field: The medicine.

Advantages over analogues: Due to their ability to accumulate in the areas of bone damage, palladium bisphosphonates exhibit antitumor activity at the level of the classic cisplatin drug, but have significantly lower toxicity; do not affect the kidneys, liver, spleen; inhibit the growth of cancer cells, blocking the development of metastases. This action increases the effectiveness of treatment, reduces its cost.

The development stage readiness: tested in laboratory condition

Description of the development:
()
The synthesized new compounds of palladium with bisphosphonated acids are substances of targeted action when they are introduced into the body of a sick person, they are locally concentrated in the bone tissue. At the same time, deactivate cancer cells and prevent the formation of metastases in the bones.

corresponds technical description
Guarantees stable results getting

Possibility of transfer abroad:
Combinated reduction to industrial level

Photo

Country Ukraine

For additional information turn to:
E-mail: gal@uintei.kiev.ua

or fill out the form:
Organization name :
Address :
Settlement account :
Bank :
MFO :
OKPO code :

Scientific organization tutor's data :
Surname :
Name :
Patronymic :
Scientific degree :
Phone :
Fax :
E-mail :
Cooperation proposals (joint patent, joint enterprise, assembly sale and so on :
country: